pd 98059 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, H; Shimoke, K | 1 |
| Huang, L; Sun, S; Sun, X; Wu, Y; Zhang, M | 1 |
| Chen, X; Guo, H; Guo, S; Kang, B; Mu, S; Yang, Q | 1 |
| Chen, L; Chen, WF; Chen, XH; Du, ZR; Teng, JJ; Wong, MS; Wu, L; Xu, AL | 1 |
4 other study(ies) available for pd 98059 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Chloromethyl Ketones; Amino Acid Substitution; Animals; Apoptosis; Caspase 3; Caspases; Chromones; Coumarins; Cysteine Proteinase Inhibitors; Dopamine Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavonoids; Genes, Dominant; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Morpholines; Mutagenesis, Site-Directed; Neoplasm Proteins; Nerve Growth Factor; Oligopeptides; Parkinson Disease; Parkinsonian Disorders; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoserine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Recombinant Fusion Proteins; Signal Transduction; Transfection | 2001 |
Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Blotting, Western; Cell Survival; Chromones; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Insulin-Like Growth Factor I; Lithium Chloride; Morpholines; Neurotoxins; Parkinson Disease; PC12 Cells; Protein Kinase Inhibitors; Rats; Recombinant Proteins | 2010 |
Ape1 protects against MPP+-induced neurotoxicity through ERK1/2 signaling in PC12 cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cell Differentiation; DNA-(Apurinic or Apyrimidinic Site) Lyase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; MAP Kinase Signaling System; Nerve Growth Factor; Neurons; PC12 Cells; Rats; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection; Up-Regulation | 2017 |
Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chromones; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Drugs, Chinese Herbal; Enzyme Inhibitors; Epimedium; Female; Flavonoids; MAP Kinase Signaling System; Mice, Inbred C57BL; Morpholines; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinase; Phosphorylation; Phytotherapy; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine 3-Monooxygenase | 2017 |